BioCentury
ARTICLE | Clinical News

NGAL Test regulatory update

July 11, 2016 7:00 AM UTC

BioPorto said it will continue to seek FDA approval of its NGAL Test to detect acute kidney injury following discussions with the agency and anticipates “approval within 18-24 months.” In late May, FD...